Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
NEO: NeoGenomics, Inc. Stock Analysis | finqOS
Healthcare · Medical - Diagnostics & Research
The Story
NEO
The Story
NEO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Operating margin
-8.6%
ROIC
-5.0%
Financially safe
Stretched
Debt / equity
0.57×
Interest coverage
-25.6×
Current ratio
3.60×
NeoGenomics, Inc.
NEO
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
NeoGenomics, Inc.
NEO
NASDAQ
·
USD
·
Closed
$15.29
−3.72%
$15.29
−$0.59 (3.72%)
52W Range
92th
pctl
Volume
1.02×
avg
Mkt Cap
392.88M
USD
P/E
-7.7
TTM
Div Yield
–
ann
52W Range
92th
pctl
Volume
1.02×
avg
Market Cap
392.88M
USD
P/E Ratio
-7.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings